Top FDA Drug Chief Resigns While Under Investigation

The FDA White Oak Campus, headquarters of the U.S. Food and Drug Administration

Key Takeaways

  • Dr. George Tidmarsh resigned Sunday while under investigation

  • Tidmarsh says he was targeted after questioning a new fast-track drug approval program

  • A separate lawsuit accuses Tidmarsh of 'revenge,' which he denies

Originally published on healthday.com, part of the BLOX Digital Content Exchange.